H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54% Market Closed
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huakang Biomedical Holdings Co Ltd
Capital Expenditures Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Capital Expenditures
-ÂĄ1.5m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Capital Expenditures
-HK$10.9m
CAGR 3-Years
-3%
CAGR 5-Years
13%
CAGR 10-Years
10%
K
Kelfred Holdings Ltd
HKEX:1134
Capital Expenditures
-HK$15.7m
CAGR 3-Years
-43%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Capital Expenditures
-HK$79.6m
CAGR 3-Years
-9%
CAGR 5-Years
-24%
CAGR 10-Years
4%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Capital Expenditures
-$7.5m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Capital Expenditures?
Capital Expenditures
-1.5m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Capital Expenditures amounts to -1.5m CNY.

What is Huakang Biomedical Holdings Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
12%

Over the last year, the Capital Expenditures growth was -85%. The average annual Capital Expenditures growth rates for Huakang Biomedical Holdings Co Ltd have been 10% over the past three years , 12% over the past five years .

Back to Top